Journal profile · CHEMISTRY, MEDICINAL
Research in Pharmaceutical Sciences
ISSN 1735-5362 · eISSN 1735-9414 · Wolters Kluwer Medknow Publications · India
Research in Pharmaceutical Sciences: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.3 (journal website); JCR Q3 (journal website); fully open access; APC about USD 500; median 169 days to acceptance (76 articles, last 24 months); 70 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Research in Pharmaceutical Sciences is published by Wolters Kluwer Medknow Publications and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Synthesis and biological activity, Advanced Drug Delivery Systems and Phytochemistry and Biological Activities, together about 22.8% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): CHEMISTRY, MEDICINAL
Editor-in-chief Jaber EmamiPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Synthesis and biological activityChemistry9.4%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics7.4%
- Phytochemistry and Biological ActivitiesAgricultural and Biological Sciences6%
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences5.3%
- Analytical Methods in PharmaceuticalsChemistry5.3%
- Nanoparticle-Based Drug DeliveryMaterials Science5.2%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics5.1%
- Computational Drug Discovery MethodsComputer Science4.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Chemistry, Medicinal | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Chemistry, Medicinal | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
JCR / CiteScore quartiles on the journal's website
- JCR Q3 · CHEMISTRY, MEDICINAL · rank 53/72
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2.3Publisher website ·
- CiteScore 2026-06
- 4.1LetPub ·
- SJR 2026-06
- 0.54LetPub ·
- SNIP 2026-06
- 0.8LetPub ·
- h-index
- 36OpenAlex ·
- i10-index
- 318OpenAlex ·
- 2-year mean citedness
- 2.43OpenAlex ·
- Self-citation rate
- 8.7%LetPub ·
- Share of gold OA articles
- 96.67%LetPub ·
Volume
- Articles per year
- 60LetPub ·
Articles by year OpenAlex count · 1,607 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 40 | 40 | 3 |
| 2025 | 70 | 70 | 160 |
| 2024 | 60 | 60 | 250 |
| 2023 | 51 | 51 | 442 |
| 2022 | 61 | 61 | 566 |
| 2021 | 60 | 60 | 782 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
169 daysMedian, submission to acceptance · P25–P75 102 days – 260 days
- Acceptance to online
- median 180 days (76 articles)
- Submission to online
- median 353 days
- Sample
- 76 articles with submission and acceptance dates (120 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 34 weeksLetPub ·
- Submission to publication (journal-reported)
- about 32 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | IRR 12,000,000 / USD 500 | No | CC BY-NC-SA | |
| OpenAlex | USD 500 / IRR 10,000,000 | — | — | |
| LetPub | USD 500 / IRR 10,000,000 | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted1
- researchResearchLength not stated
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wolters Kluwer Medknow Publications
- Country or region
- India
- Language
- English
- ISSN
- 1735-5362
- Electronic ISSN
- 1735-9414
- Latest issue on the website
- Volume 21, Issue 5 (October 2026)
- Official links
FAQ
Frequently asked questions about Research in Pharmaceutical Sciences
What CAS zone is Research in Pharmaceutical Sciences in?
In the 2025 upgraded edition of the CAS Journal Ranking, Research in Pharmaceutical Sciences is in Zone 4 of Medicine, and in Zone 4 of the minor category Chemistry, Medicinal. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Research in Pharmaceutical Sciences?
The journal's website gives an impact factor of 2.3; this is the journal's own figure, as LetPub lists none for it; CiteScore 4.1, h-index 36.
How long does peer review take at Research in Pharmaceutical Sciences?
Based on the dates recorded on 76 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 169 days (interquartile range 102–260 days); authors report an average review time of about 34 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Research in Pharmaceutical Sciences in?
The journal's website gives JCR Q3; by category, CHEMISTRY, MEDICINAL Q3 (53/72). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Which databases index Research in Pharmaceutical Sciences?
According to LetPub and DOAJ records, Research in Pharmaceutical Sciences is indexed in ESCI, Scopus and DOAJ.
Is Research in Pharmaceutical Sciences open access, and what is the APC?
Research in Pharmaceutical Sciences is a fully open-access journal. APC about USD 500.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .